BioAtla (BCAB) Shares Issued (2020 - 2026)

BioAtla's Shares Issued history runs 7 years deep, the most recent figure standing at $102542.0 for Q1 2026.

• On a quarterly basis, Shares Issued fell 98.31% year-over-year to $102542.0 in Q1 2026; TTM through Mar 2026 was $102542.0, a 98.31% decrease from a year earlier, with the FY2025 full-year figure at $117581.0, down 98.07% from the prior year.
• Shares Issued slipped to $102542.0 in Q1 2026 per BCAB's latest filing, from $117581.0 in the prior quarter.
• Across five years, Shares Issued topped out at $6.6 million in Q2 2023 and bottomed at $102542.0 in Q1 2026.
• The 5-year median for Shares Issued is $2.7 million (2022), against an average of $3.3 million.
• Across the five-year window, Shares Issued soared 34996.55% in 2022 and plunged 98.31% in 2026, its largest moves.
• Year by year, Shares Issued stood at $2.7 million in 2022, then soared by 129.22% to $6.3 million in 2023, then fell by 2.83% to $6.1 million in 2024, then sank by 98.07% to $117581.0 in 2025, then retreated by 12.79% to $102542.0 in 2026.
• Per Business Quant, the three latest BCAB Shares Issued figures stand at $102542.0 (Q1 2026), $117581.0 (Q4 2025), and $5.9 million (Q3 2025).